Business
Tokyo-based Diagnostics Firm Fujirebio Aims to Seek US Approval for Alzheimer's Blood ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Tokyo-based diagnostics firm Fujirebio aims to seek US approval for Alzheimer's blood tests as early as 2023 ...'
Tokyo-based diagnostics firm Fujirebio aims to seek US approval for Alzheimer's blood tests as early as 2023 https://t.co/OzQ0znRxI0— Bloomberg (@business) December 27, 2022
(The above story first appeared on LatestLY on Dec 28, 2022 05:01 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
